Stem Cells, Cancer Treatment, Biopharmaceuticals, Therapy

Jasper Therapeutics, Inc. (JSPR)

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies.

Nkarta, Inc. (NKTX)

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease.

Candel Therapeutics, Inc. (CADL)

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients.



Additional Sponsored Content

The One Proven Strategy That’s Helping Everyday Investors Bank Millions

Should You Be Selling Your Stocks Or Buying More?

From Ordinary to Millionaire: How Investors Are Cashing In Big



Trade Stocks Confidently: Take the Guesswork Out of Your Stock Trades

X